[ad_1]
There is new evidence that getting enough vitamin D provides significant support in protecting hospitalized people infected with Covid-19 from adverse outcomes.
Researchers at Boston University School of Medicine (BUSM) analyzed data from 235 people who were admitted to the hospital with Covid-19. They found that patients over the age of 40 were 51.5 percent less likely to die from the infection if they had a sufficient level of vitamin D, which they define as at least 30 ng / ml.
Dr. Michael F. Holick, lead author of the study and professor of medicine, physiology and biophysics and molecular medicine at BUSM, says: “This study provides direct evidence that vitamin D sufficiency can reduce complications, including the storm of cytokines (releasing too many proteins into the blood too quickly) and ultimately death from Covid-19. “
Study patients were followed to determine the following clinical outcomes, including clinical severity of infection:
Be unconscious
· Having trouble breathing that results in hypoxia and death.
Blood test for inflammatory markers (C-reactive protein
Blood tests to determine the number of lymphocytes
All parameters compared between groups of patients divided by vitamin D deficiency and sufficient vitamin D
Dr. Holick recently published a separate study that found that having a sufficient level of vitamin D can reduce the risk of contracting Covid-19 by 54 percent. He also believes that having adequate levels of vitamin D helps prevent other viruses that cause upper respiratory diseases, including influenza.
Holick adds: “Because vitamin D deficiency and insufficiency is so widespread in children and adults in the United States and around the world, especially in the winter months, it is prudent for everyone to take a vitamin D supplement to reduce the risk of infection and complications from COVID-19. “